ConductScience.org, home

Gene · 55937

APOM: apolipoprotein M

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. APOM: apolipoprotein M. Genes, record 55937. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55937

On this page

Gene

Symbol
APOM
HGNC
Name
apolipoprotein M
HGNC
NCBI Gene ID
55937
NCBI Gene
HGNC ID
HGNC:13916
HGNC
Ensembl
ENSG00000204444
NCBI Gene
Aliases
Apo-M, G3a, HSPC336, NG20, apo-M
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O95445Apolipoprotein M1883Ensembl, GeneID, HGNC

Source UniProt

Patents170

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-199711O95445Espacenet
JP 2025147176 A2025-10-061012O95445Espacenet
JP 2025138725 A2025-09-252489O95445Espacenet
JP 2025138725 A2025-09-252600O95445Espacenet
JP 2025138725 A2025-09-252897O95445Espacenet
JP 2025138725 A2025-09-252930O95445Espacenet
JP 2025138725 A2025-09-252940O95445Espacenet
JP 2025138725 A2025-09-252974O95445Espacenet
JP 2025138725 A2025-09-253006O95445Espacenet
JP 2025529142 A2025-09-045514O95445Espacenet

1 to 10 of 170

See all 170 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants849

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAPOM papersNewest fiscal year
P30DK017047Diabetes Research Center82025
P01HL116263HDL Function in Human Disease52025
P30DK035816Nutrition Obesity Research Center42025
P30DK056341Washington University Nutrition Obesity Research Center42025
ZIADK056014Mouse Models of Novel Sphingolipid Biology and Disease Mechanisms42025
P01HL128203Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity32025
P30CA016059Massey Cancer Center - Cancer Center Support Grant32025
P30DK020579Diabetes Research Center32025
R01EY031715G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.32025
R01HL155344Apolipoprotein M: a novel regulator of myocardial Autophagy32025

1 to 10 of 849Source NIH's project files

See all 849 nih grants

Papers1,335

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Mapping the Immune cell-specific gene regulatory network in bipolar disorder: A framework from scTWMR to exploratory drug-target annotation.Psychiatry Res202642743600PubTator, text miningPubMed
Unraveling causal links between chronic rhinosinusitis and peripheral artery diseases: insights from genetic correlations through genome-wide association studies.Braz J Otorhinolaryngol202642685396PubTator, text miningPubMed
Mapping the immune-genetic architecture of Epstein-Barr virus-related phenotypes and multiple sclerosis through a single-cell genetic framework for target prioritization and pharmacologic hypothesis generation.
Mult Scler Relat Disord202642570508PubTator, text miningPubMed
The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid Carcinoma.Life (Basel)202642514153PubTator, text miningPubMed
Exploring Targets for Heart Failure Using Mendelian Randomization, Colocalization, Summary Data-based Mendelian Randomization, and Drug Prediction.J Vis Exp202642507612PubTator, text miningPubMed
Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators.JACC CardioOncol202642455107PubTator, text miningPubMed
APOM-S1P axis as a therapeutic target in steroid sensitive nephrotic syndrome.Pediatr Nephrol202642400614PubTator, text miningPubMed
Longitudinal Cognitive Evolution in Alcohol Use Disorder Patients: Role of Inflammation, Time of Abstinence and Apolipoprotein Profile.Addict Biol202642386626PubTator, text miningPubMed
Alterations of sphingosine-1-phosphate and its receptors in type 1 diabetes mellitus: an integrated clinical and single-cell transcriptomic study.Front Immunol202642338584PubTator, text miningPubMed
Unravelling the conformational dynamics of pathogenic mutations of apolipoprotein M: an integrative computational and molecular dynamics simulation approach.J Biomol Struct Dyn202642301260PubTator, text miningPubMed

1 to 10 of 1,335

See all 1,335 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/55937

GET https://conductscience.org/api/genes/v1/55937/patents?page=2